Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
IMMUNOTHERAPEUTIC DOSING REGIMENS COMPRISING POMALIDOMIDE AND AN ANTI-CS1 ANTIBODY FOR TREATING CANCER
No-Receipt date
2021-03569 - 16/09/2021
No-Filing date
20210402475 - 16/09/2021
No-Granting date
3108389 - 24/09/2021
No-EPO application date
16738609.3 - 28/06/2016
No-EPO granting date
3313528 - 04/08/2021
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
9/2021 - 13/10/2021
Expiration date
29/06/2036
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201562185968 P29/06/2015/US
US201562239965 P11/10/2015/US
US201562262574 P03/12/2015/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61P 35/02
A61K 39/395
A61K 31/573
A61K 31/454
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1350359
BRISTOL-MYERS SQUIBB COMPANY
ROUTE 206 AND PROVINCE LINE ROAD
PRINCETON, NJ 08543
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
3467787
MULLIGAN, CHRISTOPHER LEE
3467788
BARTLETT, JUSTIN BLAKE
3467789
ROBBINS, MICHAEL DARRON
Representatives
Code
Firstname
Surname
Address
Town
Zip
3712
ANTHOULA
GALANOPOULOU
THESI LYSI MPITAKOU
KAPANDRITI (ATTIKIS)
19014
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
9219
ALKISTIS-EIRINI
MALAMI
VISSARIONOS 3
ATHINA (ATTIKIS)
10672
GREECE
Owners History
Title Instruments
Payments history
9 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).